
Beyond the Headlines of MAHA With the FDA
Chasing Life
00:00
Mifepristone Review and Post‑Approval Surveillance
Makary outlines the FDA's response to external reports and attorney general letters about mifepristone and describes plans for systematic big-data post‑approval monitoring.
Play episode from 22:18
Transcript


